#46 Adapting anti-rejection treatment in a failing renal graft, with Cristophe Mariat

Update: 2025-06-19

Description

Christophe Mariat, from Saint-Étienne, France, and Chair of the ERA DESCaRTES Working Group, takes us through the complex topic of adapting anti-rejection treatment in the context of a failing renal graft. He shares valuable insights on renal graft survival rates, strategies for adjusting immunosuppressive treatments when the kidney starts failing, and the adaptations needed in antirejection strategies once dialysis is resumed.

Comments

In Channel

Trailer Primary hyperoxaluria type 1, Antibody-mediated rejection treatment – now and in the future and Sustainable nephrology

2025-10-0202:05

#51 Monoclonal gammopathy with renal significance, with Jolanta Małyszko

2025-09-1128:47

#50 Onconephrology: A huge subject, with Kenar D. Jhaveri

2025-09-1115:48

#49 Obesity and CKD, with Marieta Theodorakopoulou

2025-09-1123:17

Trailer Obesity and CKD, Onconephrology: A huge subject and Monoclonal gammopathy with renal significance

2025-09-0401:52

#48 Xenotransplantation: Is it for real? with David Cooper

2025-06-1931:01

#47 Infection prophylaxis for renal transplant recipients in 2025, with Ilaria Gandolfini

2025-06-1928:27

#46 Adapting anti-rejection treatment in a failing renal graft, with Cristophe Mariat

2025-06-1915:43

Trailer Adapting anti-rejection treatment in a failing renal graft, Infection prophylaxis for renal transplant recipients in 2025 and Xenotransplantation: Is it for real?

2025-06-1202:29